1. Active surveillance for multidrug-resistant Gram-negative bacteria in the intensive care unit
- Author
-
David L. Paterson, Iain J. Abbott, Adam Jenney, Leisha J. Richardson, Anton Y. Peleg, Hanna E. Sidjabat, David Pilcher, and Denis Spelman
- Subjects
Cross Infection ,business.industry ,Ceftazidime ,Drug Resistance, Microbial ,Drug resistance ,Intensive care unit ,Pathology and Forensic Medicine ,Microbiology ,law.invention ,Cohort Studies ,Intensive Care Units ,chemistry.chemical_compound ,Antibiotic resistance ,chemistry ,law ,Intensive care ,medicine ,Humans ,Gentamicin ,Screening cultures ,Gram-Negative Bacterial Infections ,business ,MacConkey agar ,medicine.drug - Abstract
A short-term program of performing serial active screening cultures (ASC) in the intensive care unit was instituted to establish a method for the detection of antibiotic-resistant Gram-negative bacteria (GNB) and the local rates of colonisation. Of all submitted ASC, 25.9% (30/116 collected swabs) isolated an antibiotic-resistant GNB. ChromID ESBL agar (bioMérieux, France) identified the majority of these organisms, with the additional antibiotic-impregnated media [MacConkey agar (MCA) with ciprofloxacin, MCA with gentamicin and MCA with ceftazidime] adding limited benefit. Compared to swabs performed on admission, 37.8% (14/37) of patients cultured a new antibiotic-resistant isolate on discharge. Serial screening in intensive care has the ability to identify patients with unrecognised colonisation with antibiotic-resistant GNB; however, the increase in the laboratory workload and logistical challenges in the collection of the surveillance swabs may limit this program's expansion.
- Published
- 2015